- Conditions
- Congenital Heart Disease
- Interventions
- Bosentan
- Drug
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 12 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Feb 26, 2015 · Synced May 22, 2026, 12:52 AM EDT